Published in Am J Sports Med on March 10, 1997
Quality of tibial fixation in ACL reconstructions. Am J Sports Med (1997) 0.75
Childhood and adult socioeconomic status as predictors of mortality in Finland. Lancet (1994) 6.02
Urinary prostaglandins. Identification and origin. J Clin Invest (1975) 3.07
Recommendations from the Canadian Hypertension Society Consensus Conference on Hypertension and Diabetes. CMAJ (1988) 2.36
Prevalence and predictors of white-coat response in patients with treated hypertension. CMAJ (1999) 2.26
Radioimmunoassay for measurement of gentamicin in blood. Antimicrob Agents Chemother (1973) 2.08
Increased prescribing of antidepressants subsequent to beta-blocker therapy. Arch Intern Med (1990) 1.92
Kinetics of the homogeneous freezing of water. Phys Chem Chem Phys (2010) 1.47
Reversibility of catecholamine-induced cardiomyopathy in a woman with pheochromocytoma. CMAJ (1989) 1.45
Binge drinking among undergraduate college students in the United States: implications for other substance use. J Am Coll Health (2001) 1.32
Social functioning and overall mortality: prospective evidence from the Kuopio Ischemic Heart Disease Risk Factor Study. Epidemiology (1994) 1.28
Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring. Can J Cardiol (1997) 1.26
The effects of continuing medical education on family doctor performance in office practice: a randomized control study. Med Educ (1988) 1.24
Water sorption and mechanical properties of light-cured proprietary composite tooth restorative materials. Biomaterials (1992) 1.07
Renal P450 metabolites of arachidonic acid and the development of hypertension in Dahl salt-sensitive rats. Am J Hypertens (1997) 1.06
Elimination of tritiated gentamicin in normal human subjects and in patients with severely impaired renal function. Clin Pharmacol Ther (1973) 1.05
Improving physician performance by continuing medical education. Can Med Assoc J (1978) 1.04
Blood pressure in blacks. Twin studies in Barbados. Hypertension (1990) 1.02
Indomethacin increases the formation of lipoxygenase products in calcium ionophore stimulated human neutrophils. Biochem Biophys Res Commun (1987) 1.01
Eye injuries in childhood: demography, etiology, and prevention. Pediatrics (1989) 0.99
Dose-related antihypertensive effects of irbesartan in patients with mild-to-moderate hypertension. Am J Hypertens (1998) 0.98
Effect of dosage regimen on natriuretic response to furosemide. Clin Pharmacol Ther (1975) 0.95
History of salt supplies in West Africa and blood pressures today. Lancet (1986) 0.94
The 2000 Canadian recommendations for the management of hypertension: part two--diagnosis and assessment of people with high blood pressure. Can J Cardiol (2001) 0.92
Temporal contrast sensitivity loss in primary open-angle glaucoma and glaucoma suspects. Invest Ophthalmol Vis Sci (1991) 0.92
Heterogeneity in vascular smooth muscle responsiveness to angiotensin II. Role of endothelin. Hypertension (1995) 0.91
Accuracy of the Dinamap 1846 XT automated blood pressure monitor. J Hum Hypertens (2002) 0.91
Fenofibrate lowers blood pressure in two genetic models of hypertension. Can J Physiol Pharmacol (2000) 0.90
Oral ingestion of narcotic analgesics by rats. J Pharmacol Exp Ther (1976) 0.89
Altered paracrine effect of endothelin in blood vessels of the hyperinsulinemic, insulin resistant obese Zucker rat. Cardiovasc Res (2000) 0.89
Timolol and propranolol: bioavailability, plasma concentrations, and beta blockade. Clin Pharmacol Ther (1982) 0.85
Silsoft extended wear contact lenses in pediatric aphakia. Ophthalmology (1985) 0.85
Insulin and vanadate restore decreased plasma endothelin concentrations and exaggerated vascular responses to normal in the streptozotocin diabetic rat. Diabetologia (1998) 0.85
Lifestyle profiles of hypertensives. Can J Cardiovasc Nurs (1991) 0.85
The necessity of drug level monitoring in anticonvulsant drug therapy. Can J Physiol Pharmacol (1976) 0.84
Effect of an endothelin antagonist on hemodynamic responses to angiotensin II. Hypertension (1996) 0.84
Differential effects of phosphoramidon on contractile responses to angiotensin II in rat blood vessels. Br J Pharmacol (1995) 0.84
A competitive protein binding assay specific for prostaglandin E. Biochim Biophys Acta (1974) 0.83
ETB receptors on aortic smooth muscle cells of spontaneously hypertensive rats. Am J Physiol (1993) 0.83
A gas chromatographic method for measuring 6-mercaptopurine in serum. J Chromatogr (1975) 0.83
Amantadine-dyazide interaction. Can Med Assoc J (1983) 0.83
Social factors in alexithymia. Compr Psychiatry (1994) 0.82
Insulin increases endothelin-1-evoked intracellular free calcium responses by increased ET(A) receptor expression in rat aortic smooth muscle cells. Diabetes (1998) 0.82
Predicting success in antihypertensive drug therapy: the importance of nondrug variables. Can J Cardiol (1991) 0.81
Furosemide increases urine 6-keto-prostaglandin F1 alpha. Relation to natriuresis, vasodilation, and renin release. Hypertension (1982) 0.81
The association of congenital ptosis and congenital heart disease. Ophthalmology (1986) 0.80
Effects of low-dose aspirin on responses to furosemide. J Clin Pharmacol (1986) 0.79
Insulin-induced biphasic responses in rat mesenteric vascular bed: role of endothelin. Hypertension (2001) 0.79
Endothelin antagonist reduces hemodynamic responses to vasopressin in DOCA-salt hypertension. Am J Physiol Heart Circ Physiol (2001) 0.79
Transcutaneous delivery of prostaglandin E1: in vitro and laser doppler flowmetry study. J Pharm Sci (1998) 0.78
Responses to furosemide in normotensive and hypertensive subjects. Clin Pharmacol Ther (1983) 0.78
Substance use on school property among students attending alternative high schools in the United States. J Drug Educ (2001) 0.78
Testing the "redirection hypothesis" of prostaglandin metabolism in the kidney. Prostaglandins (1987) 0.77
Factors affecting graft excursion patterns in endoscopic anterior cruciate ligament reconstruction. Knee Surg Sports Traumatol Arthrosc (1998) 0.77
Effect of furegrelate on renal plasma flow after angiotensin II infusion. Can J Physiol Pharmacol (1990) 0.77
Biomechanical properties of the central third patellar tendon graft: effect of rotation. Knee Surg Sports Traumatol Arthrosc (1998) 0.76
Nuclear Ca2+ signaling to endothelin-1 in rat aortic smooth-muscle cells. J Cardiovasc Pharmacol (1998) 0.76
Effect of indomethacin on arachidonic acid metabolism in human leukocytes stimulated ex vivo. Clin Pharmacol Ther (1991) 0.76
Effects of indomethacin on furosemide induced renal prostaglandin synthesis and action in man. Clin Invest Med (1986) 0.76
Effects of ridogrel, a thromboxane synthase inhibitor and receptor antagonist, on blood pressure in the spontaneously hypertensive rat. Jpn J Pharmacol (1998) 0.76
Angle closure glaucoma complicating systemic atropine use in the cardiac catheterization laboratory. Cathet Cardiovasc Diagn (1996) 0.76
Sudden death in a patient with chronic lymphocytic leukemia. CMAJ (1998) 0.75
New drugs for the treatment of hypertension: where do they fit? Can Fam Physician (1987) 0.75
Lead poisoning: unusual manifestation and unusual source. CMAJ (1986) 0.75
The Saskatchewan Heart Foundation Blood Pressure Survey: The efficacy of community-based detection and referral programs. Can Fam Physician (1991) 0.75
The relative bioavailability of a commercial propranolol hydrochloride tablet in man. Biopharm Drug Dispos (1982) 0.75
Effect of losartan on angiotensin II-mediated endothelin and prostanoid excretion in humans. Am J Hypertens (2000) 0.75
Dosage, compliance and bioavailability in perspective. Can Med Assoc J (1977) 0.75
Effect of cyclooxygenase and thromboxane synthetase inhibition on furosemide-stimulated plasma renin activity. Can J Physiol Pharmacol (1987) 0.75
Africa, Afro-Americans, and hypertension: an hypothesis. Soc Sci Hist (1986) 0.75
Pharmacokinetics of glucuronidation of propranolol following oral administration in humans. Biopharm Drug Dispos (1984) 0.75
The antihypertensive action of hydrochlorothiazide and renal prostacyclin. Clin Pharmacol Ther (1986) 0.75
Diuretic and non-diuretic actions of furosemide: effects of probenecid. Clin Invest Med (1992) 0.75
Letter: Drug bioavailability. Can Med Assoc J (1976) 0.75
Diltiazem potentiates angiotensin II-mediated renal prostacyclin synthesis. J Cardiovasc Pharmacol (1992) 0.75
Dynamic mechanical properties of straight titanium alloy arch wires. Dent Mater (1990) 0.75
Pheochromocytoma: an unusual presentation and sequela. Can J Cardiol (1992) 0.75
Stratified initial values and change scores. Methods Inf Med (1993) 0.75
Image processing by computer analysis--potential use and application in civil and criminal litigation. Leg Med (1990) 0.75
Sulindac does not spare renal prostaglandins. Clin Invest Med (1989) 0.75
Losartan: a new antihypertensive drug. Can Nurse (1997) 0.75
A renal vasodilator effect of angiotensin II revealed by dual thromboxane inhibition. Can J Physiol Pharmacol (1994) 0.75
Differential regulation of endothelin-1 action by insulin and vanadate in vascular smooth muscle. J Cardiovasc Pharmacol (1998) 0.75
Determination of 6-keto-prostaglandin F1 alpha and thromboxane B2 in urine by high-performance liquid chromatography and radioimmunoassay. J Chromatogr (1984) 0.75
Some pharmacological properties of althesin (CT1341) in man. Can Anaesth Soc J (1975) 0.75
Lifestyle behaviors in treated hypertensives as prediction of blood pressure control. Rehabil Nurs (1988) 0.75
The team approach. Can Nurse (1994) 0.75
Characterization of polydimethacrylates and their composites by dynamic mechanical analysis. J Dent Res (1987) 0.75
Cysteinyl leukotrienes mediate enhanced vasoconstriction to angiotensin II but not endothelin-1 in SHR. Am J Physiol Heart Circ Physiol (2001) 0.75
Low plasma renin activity in diabetes. Relation to urine prostaglandin excretion. Diabetes (1985) 0.75
AGT and RH blood group polymorphisms affect blood pressure and lipids in Afro-Caribbeans. J Hum Hypertens (2004) 0.75
Desirable behaviours in the office management of hypertension addressed through continuing medical education. Can J Public Health (1989) 0.75
Designing education interventions to improve physician performance in office practice. Mobius (1984) 0.75